CoChat

In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer

Open access
Carugo, Alessandro, Genovese, Giannicola, Seth, Sahil, Nezi, Luigi, Rose, Johnathon Lynn, Bossi, Daniela, Cicalese, Angelo, Shah, Parantu Krushnakant, Viale, Andrea, Pettazzoni, Piergiorgio Francesco, Akdemir, Kadir Caner, Bristow, Christopher Aaron, Robinson, Frederick Scott, Tepper, James, Sanchez, Nora, Gupta, Sonal, Estecio, Marcos Roberto, Giuliani, Virginia, Dellino, Gaetano Ivan, Riva, Laura, Yao, Wantong, Di Francesco, Maria Emilia, Green, Tessa, D’Alesio, Carolina, Corti, Denise, Kang, Ya’an, Jones, Philip, Wang, Huamin, Fleming, Jason Bates, Maitra, Anirban, Pelicci, Pier Giuseppe, Chin, Lynda, DePinho, Ronald Anthony, Lanfrancone, Luisa, Heffernan, Timothy Paul, Draetta, Giulio Francesco · 2016 · Cell Reports
Cited by 141

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Current treatment regimens for pancreatic ductal adenocarcinoma (PDAC) yield poor 5-year survival, emphasizing the critical need to identify druggable targets essential for PDAC maintenance. We developed an unbiased and in vivo target discovery approach to identify molecular vulnerabilities in low-passage and patient-derived PDAC xenografts or genetically engineered mouse model-derived allografts. Focusing on epigenetic regulators, we identified WDR5, a core member of the COMPASS histone H3 Lys4 (H3K4) MLL (1-4) methyltransferase complex, as a top tumor maintenance hit required across multiple human and mouse tumors. Mechanistically, WDR5 functions to sustain proper execution of DNA replication in PDAC cells, as previously suggested by replication stress studies involving MLL1, and c-Myc, also found to interact with WDR5. We indeed demonstrate that interaction with c-Myc is critical for this function. By showing that ATR inhibition mimicked the effects of WDR5 suppression, these data provide rationale to test ATR and WDR5 inhibitors for activity in this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2016.05.063

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 45

  1. Almoguera, 1988, Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes, Cell, 53, 549, 10.1016/0092-8674(88)90571-5 · DOI · Paper page
  2. Baratta, 2015, An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma, Proc. Natl. Acad. Sci. USA, 112, 232, 10.1073/pnas.1422165112 · DOI · Paper page
  3. Bonnefoix, 2010, Revisiting the concept of phenotypically distinct malignant pancreatic stem-cell subsets based on limiting dilution transplantation assays, J. Clin. Oncol., 28, e89, 10.1200/JCO.2009.25.0282 · doi:10.1200/jco.2009.25.0282
  4. Campaner, 2012, Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance, Cell Div., 7, 6, 10.1186/1747-1028-7-6 · DOI
  5. Cao, 2014, Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia, Mol. Cell, 53, 247, 10.1016/j.molcel.2013.12.001 · DOI · Paper page
  6. Chen, 2015, Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation, Sci. Rep., 5, 8293, 10.1038/srep08293 · DOI
  7. Dang, 1999, c-Myc target genes involved in cell growth, apoptosis, and metabolism, Mol. Cell. Biol., 19, 1, 10.1128/MCB.19.1.1 · DOI · Paper page
  8. Dominguez-Sola, 2007, Non-transcriptional control of DNA replication by c-Myc, Nature, 448, 445, 10.1038/nature05953 · DOI · Paper page
  9. Gaillard, 2015, Replication stress and cancer, Nat. Rev. Cancer, 15, 276, 10.1038/nrc3916 · DOI · Paper page
  10. Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J. Immunol. Methods, 347, 70, 10.1016/j.jim.2009.06.008 · DOI · Paper page
  11. Hubert, 2013, Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A, Genes Dev., 27, 1032, 10.1101/gad.212548.112 · DOI · Paper page
  12. Ischenko, 2014, Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas, Proc. Natl. Acad. Sci. USA, 111, 3466, 10.1073/pnas.1319911111 · DOI · Paper page
  13. Ishizawa, 2010, Tumor-initiating cells are rare in many human tumors, Cell Stem Cell, 7, 279, 10.1016/j.stem.2010.08.009 · DOI · Paper page
  14. Kim, 2014, A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer, Mol. Cell, 54, 613, 10.1016/j.molcel.2014.03.043 · DOI · Paper page
  15. König, 2007, A probability-based approach for the analysis of large-scale RNAi screens, Nat. Methods, 4, 847, 10.1038/nmeth1089 · DOI · Paper page
  16. Krattenmacher, 2014, Synthetic lethality screen identifies SMC2 as a new target gene in pancreatic cancer, Pancreatology, 13, S66, 10.1016/j.pan.2014.05.605 · doi:10.1016/j.pan.2014.05.605
  17. Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol., 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page
  18. Li, 2009, The Sequence alignment/map (SAM) format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352 · DOI · Paper page
  19. Liu, 2010, Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint, Nature, 467, 343, 10.1038/nature09350 · DOI · Paper page
  20. Meacham, 2009, In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression, Nat. Genet., 41, 1133, 10.1038/ng.451 · DOI · Paper page
  21. Moffat, 2006, A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen, Cell, 124, 1283, 10.1016/j.cell.2006.01.040 · DOI · Paper page
  22. Morris, 2010, Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice, J. Clin. Invest., 120, 508, 10.1172/JCI40045 · DOI · Paper page
  23. Murga, 2011, Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors, Nat. Struct. Mol. Biol., 18, 1331, 10.1038/nsmb.2189 · DOI · Paper page
  24. Omura, 2009, Epigenetics and epigenetic alterations in pancreatic cancer, Int. J. Clin. Exp. Pathol., 2, 310
  25. Possik, 2014, Parallel in vivo and in vitro melanoma RNAi dropout screens reveal synthetic lethality between hypoxia and DNA damage response inhibition, Cell Rep., 9, 1375, 10.1016/j.celrep.2014.10.024 · DOI
  26. Prevo, 2012, The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy, Cancer Biol. Ther., 13, 1072, 10.4161/cbt.21093 · DOI · Paper page
  27. Quintana, 2008, Efficient tumour formation by single human melanoma cells, Nature, 456, 593, 10.1038/nature07567 · DOI · Paper page
  28. Sahai, 2014, BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen, Mol. Cancer Ther., 13, 1907, 10.1158/1535-7163.MCT-13-0925 · DOI · Paper page
  29. Schlabach, 2008, Cancer proliferation gene discovery through functional genomics, Science, 319, 620, 10.1126/science.1149200 · DOI · Paper page
  30. Scholl, 2009, Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells, Cell, 137, 821, 10.1016/j.cell.2009.03.017 · DOI · Paper page
  31. Schoppy, 2012, Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR, J. Clin. Invest., 122, 241, 10.1172/JCI58928 · DOI · Paper page
  32. Schuettengruber, 2011, Trithorax group proteins: switching genes on and keeping them active, Nat. Rev. Mol. Cell Biol., 12, 799, 10.1038/nrm3230 · DOI · Paper page
  33. Sears, 1999, Ras enhances Myc protein stability, Mol. Cell, 3, 169, 10.1016/S1097-2765(00)80308-1 · DOI · Paper page
  34. Silva, 2008, Profiling essential genes in human mammary cells by multiplex RNAi screening, Science, 319, 617, 10.1126/science.1149185 · DOI · Paper page
  35. Smith, 2011, The super elongation complex (SEC) and MLL in development and disease, Genes Dev., 25, 661, 10.1101/gad.2015411 · DOI · Paper page
  36. Stathis, 2010, Advanced pancreatic carcinoma: current treatment and future challenges, Nat. Rev. Clin. Oncol., 7, 163, 10.1038/nrclinonc.2009.236 · DOI · Paper page
  37. Stellas, 2014, Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer, J. Natl. Cancer Inst., 106, dju320, 10.1093/jnci/dju320 · DOI
  38. Steward, 2006, Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes, Nat. Struct. Mol. Biol., 13, 852, 10.1038/nsmb1131 · DOI · Paper page
  39. Sun, 2015, WDR5 supports an N-Myc transcriptional complex that drives a protumorigenic gene expression signature in neuroblastoma, Cancer Res., 75, 5143, 10.1158/0008-5472.CAN-15-0423 · DOI
  40. Trievel, 2009, WDR5, a complexed protein, Nat. Struct. Mol. Biol., 16, 678, 10.1038/nsmb0709-678 · DOI
  41. Ventura, 2004, Cre-lox-regulated conditional RNA interference from transgenes, Proc. Natl. Acad. Sci. USA, 101, 10380, 10.1073/pnas.0403954101 · DOI · Paper page
  42. Wang, 2009, Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II, Mol. Cell. Biol., 29, 6074, 10.1128/MCB.00924-09 · DOI · Paper page
  43. Yu, 1995, Altered Hox expression and segmental identity in Mll-mutant mice, Nature, 378, 505, 10.1038/378505a0 · DOI · Paper page
  44. Zender, 2008, An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer, Cell, 135, 852, 10.1016/j.cell.2008.09.061 · DOI · Paper page
  45. Zhou, 2009, Tumour-initiating cells: challenges and opportunities for anticancer drug discovery, Nat. Rev. Drug Discov., 8, 806, 10.1038/nrd2137 · DOI · Paper page

Cited by

See all 141

Metadata

Authors
Carugo, A., Genovese, G., Seth, S., Nezi, L., Rose, J. L., Bossi, D., Cicalese, A., Shah, P. K., Viale, A., Pettazzoni, P. F., Akdemir, K. C., Bristow, C. A., Robinson, F. S., Tepper, J., Sanchez, N., Gupta, S., Estecio, M. R., Giuliani, V., Dellino, G. I., Riva, L., Yao, W., Di Francesco, M. E., Green, T., D’Alesio, C., Corti, D., Kang, Y., Jones, P., Wang, H., Fleming, J. B., Maitra, A., Pelicci, P. G., Chin, L., DePinho, R. A., Lanfrancone, L., Heffernan, T. P., & Draetta, G. F.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2016-06
Volume
16
Issue
1
Pages
133-147
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2422923474
Cited by
141
References
17
FWCI
6.34
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.